CollPlant Biotechnologies Files 2024 Annual Report
Ticker: CLGN · Form: 20-F · Filed: Mar 26, 2025 · CIK: 1631487
Sentiment: neutral
Topics: annual-report, biotechnology, sec-filing
TL;DR
CollPlant filed its 2024 20-F, check it for the latest on their ortho/prosthetic biz.
AI Summary
CollPlant Biotechnologies Ltd. filed its annual report on Form 20-F for the fiscal year ended December 31, 2024. The company, incorporated in L3 and headquartered in Rehovot, Israel, operates in the orthopedic, prosthetic, and surgical appliances and supplies industry. This filing serves as an annual report under the Securities Exchange Act of 1934.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of CollPlant's financial performance, business operations, and risk factors for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a biotechnology company, CollPlant is subject to inherent risks related to research and development, regulatory approvals, and market adoption of its products.
Key Numbers
- 2024 — Fiscal Year End (The period covered by the annual report)
- 1231 — Fiscal Year End (Specific date of fiscal year end)
Key Players & Entities
- CollPlant Biotechnologies Ltd. (company) — Filer of the 20-F
- December 31, 2024 (date) — Fiscal year end for the report
- Rehovot, Israel (location) — Company headquarters
- 3842 (industry_code) — Standard Industrial Classification for the company's business
FAQ
What is the primary business of CollPlant Biotechnologies Ltd. as indicated by its SIC code?
CollPlant Biotechnologies Ltd.'s primary business is in ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES, as indicated by its Standard Industrial Classification code 3842.
For which fiscal year is this 20-F filing reporting?
This 20-F filing is for the fiscal year ended December 31, 2024.
Where is CollPlant Biotechnologies Ltd. headquartered?
CollPlant Biotechnologies Ltd. is headquartered at 4 Oppenheimer St., 11th Floor, Rehovot, L3, 74140.
What is the SEC file number for CollPlant Biotechnologies Ltd.?
The SEC file number for CollPlant Biotechnologies Ltd. is 001-38370.
What type of filing is this document for CollPlant Biotechnologies Ltd.?
This document is an annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, specifically a Form 20-F.
Filing Details
This Form 20-F (Form 20-F) was filed with the SEC on March 26, 2025 regarding CollPlant Biotechnologies Ltd (CLGN).